Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

735.39
+0.58260.08%
Volume:209.64K
Turnover:153.94M
Market Cap:75.71B
PE:18.19
High:742.50
Open:740.00
Low:729.20
Close:734.81
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.39
T/O Rate:0.21%
Dividend:3.64
Dividend Rate:0.49%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.39
PE(LYR):17.73

Loading ...

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

CytomX Highlights Varseta-M EpCAM Topo-1 ADC Data in Late-Line Metastatic Colorectal Cancer Presentation

Reuters
·
Sep 09

Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000

Reuters
·
Sep 04

Regeneron Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 04

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Reuters
·
Sep 03

Regeneron Announces Q3 2026 Dividend of R$ 0.05 Per Unit

Reuters
·
Sep 03

Movement Alert|Regeneron Pharmaceuticals Rises 3.05% in Regular Trading, RBC Says Company Weighing Expanded Sanofi Partnership

Market Focus
·
Sep 03

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Movement Alert|Regeneron Pharmaceuticals Rises 3.01% in Regular Trading, RBC Says Company Weighing Expanded Sanofi Partnership

Market Focus
·
Sep 02

Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says

MT Newswires Live
·
Sep 01

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-01

Reuters
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.
·
Sep 01

Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million

Reuters
·
Aug 27

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Reuters
·
Aug 27

Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 27

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Aug 25

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Aug 25